issues of the SAMJ, entitled 'da Vinci Transoral Robotic Surgery (TORS) is a minimally invasive alternative to open surgery and full-dose chemoradiation therapy for diseases of the head and neck' . As these advertisements go beyond simply marketing surgical equipment, but seek to influence patients, referring doctors, oncologists and head and neck surgeons on how to treat cancers of the head and neck and sleep apnoea, we have taken the unusual step of writing to the editor of the SAMJ to correct some misconceptions in the advertisement.
base of tongue -will require adjuvant treatment to the postoperative tumour bed and/or the neck. If the tumour is excised with positive margins or the lymph nodes have extracapsular spread, many oncologists would still advocate chemoradiation. In theory, if a tumour of the base of tongue is excised, the postoperative radiotherapy target area may be smaller than if the tumour had not been excised. This in turn could result in at least some sparing of the pharyngeal constrictor muscles. However, this theoretical advantage would not be limited to TORS, but would apply to all the surgical techniques mentioned above.
Several randomised controlled trials are currently underway to better define the impact of TORS on the treatment of oropharyngeal cancers. In one such study the option of de-escalated treatment after TORS is being examined in patients with human papillomavirus (HPV)-positive tumours, while another study is comparing TORS with/without adjuvant treatment to chemoradiation in patients with HPV-negative tumours. Until the results of these and other studies are available, the role that TORS (or any surgery that achieves clear surgical margins) may or may not play in reducing the need for chemoradiotherapy is not known.
Therefore, even though TORS is an established surgical technique, it is extremely expensive in the SA context when there are cheaper alternatives available. 
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